Home/Filings/4/0001209191-23-038033
4//SEC Filing

WINSTON ROY 4

Accession 0001209191-23-038033

CIK 0001396814other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:45 PM ET

Size

7.9 KB

Accession

0001209191-23-038033

Insider Transaction Report

Form 4
Period: 2023-06-14
WINSTON ROY
Chief Clinical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-14+27,50027,500 total
    Exercise: $38.74Exp: 2033-06-14Common Stock (27,500 underlying)
  • Award

    Common Stock

    2023-06-14+10,95052,306 total
Footnotes (2)
  • [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
  • [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001751757

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:45 PM ET
Size
7.9 KB